Clinical Trials

Title   AALL15P1: A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND#TBD, NSC# 102816) to Chemotherapy in Infants with Acute Lymphoblastic Leukemia (ALL) and KMT2A Gene Rearrangement
IRB Number   17-411
Treatment   Oncology - Leukemia
Status   Active
Start Date   11/14/2017
Principal Name   Felicia Wilson M.D.
Contact Name   Andretta McCovey

Email Newsletters

Connect With Us